[Federal Register Volume 68, Number 10 (Wednesday, January 15, 2003)]
[Notices]
[Page 2073]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-768]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated June 10, 2002, and published in the Federal 
Register on June 20, 2002, (67 FR 42059), Celltech Manufacturing CA, 
Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of methylphenidate (1724), a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture the listed controlled substance to 
make finished dosage forms for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Celltech Manufacturing CA, Inc. to 
manufacture the listed controlled substance is consistent with the 
public interest at this time. DEA has investigated Celltech 
Manufacturing CA, Inc. on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security system, audits of the company's records, verification 
of the company's compliance with state and local laws, and a review of 
the company's background and history. Therefore, pursuant to 21 U.S.C. 
823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacture of 
the basic class of controlled substance listed above is granted.

    Dated: December 13, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-768 Filed 1-14-03; 8:45 am]
BILLING CODE 4410-09-M